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PhosphorylationPreviously we showed that left ventricular (LV) responsiveness to exercise-induced increases in
noradrenaline was blunted in pigs with a recent myocardial infarction (MI) [van der Velden et al. Circ Res.
2004], consistent with perturbed β-adrenergic receptor (β-AR) signaling. Here we tested the hypothesis that
abnormalities at the myoﬁlament level underlie impaired LV responsiveness to catecholamines in MI.
Myoﬁlament function and protein composition were studied in remote LV biopsies taken at baseline and
during dobutamine stimulation 3 weeks after MI or sham. Single permeabilized cardiomyocytes demon-
strated reduced maximal force (Fmax) and higher Ca2+-sensitivity in MI compared to sham. Fmax did not
change during dobutamine infusion in sham, but markedly increased in MI. Moreover, the dobutamine-
induced decrease in Ca2+-sensitivity was signiﬁcantly larger in MI than sham. Baseline phosphorylation
assessed by phosphostaining of β-AR target proteins myosin binding protein C (cMyBP-C) and troponin I
(cTnI) in MI and sham was the same. However, the dobutamine-induced increase in overall cTnI
phosphorylation and cTnI phosphorylation at protein kinase A (PKA)-sites (Ser23/24) was less in MI
compared to sham. In contrast, the dobutamine-induced phosphorylation of cMyBP-C at Ser282 was
preserved in MI, and coincided with increased autophosphorylation (at Thr282) of the cytosolic Ca2+-
dependent calmodulin kinase II (CaMKII-δC). In conclusion, in post-infarct remodeled myocardium
myoﬁlament responsiveness to dobutamine is signiﬁcantly enhanced despite the lower increase in PKA-
mediated phosphorylation of cTnI. The increased myoﬁlament responsiveness in MI may depend on the
preserved cMyBP-C phosphorylation possibly resulting from increased CaMKII-δC activity and may help to
maintain proper diastolic performance during exercise.mc, van der Boechorststraat 7,
8113; fax: +31 20 4448255.
Velden).
vier OA license.© 2010 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
The incidence of congestive heart failure has increased over the
past decade, which is principally due to a reduction in peri-infarct
mortality associated with an acute myocardial infarction (MI) [1,2].
The acute loss of function in the infarct area upon MI activates the
sympathetic nervous system in an attempt to maintain cardiac output
[3]. However, within weeks upon MI, global left ventricular (LV)function becomes depressed [4–8], which can in part be explained by
adverse remodeling of the ventricle. In addition, contractile dysfunc-
tion of cardiomyocytes in the remote non-infarcted area of the
ventricle contributes to reduced LV pump function [5–10].
Altered myoﬁlament properties have been proposed to underlie
cardiomyocyte dysfunction in post-MI remodeled myocardium [5–
8,10,11]. A chronic increase in catecholamines in response to reduced
cardiac function upon acute MI may desensitize the β-adrenergic
receptor (β-AR) pathway [8,12–14]. In a previous study,we have shown
[5] that in vivo cardiac responsiveness to exercise-induced increases in
noradrenaline was blunted in pigs with an MI, consistent with down-
regulation, uncoupling and/ordownstreamsignalingdefects of theβ-AR
cascade. In pig and mice models of cardiac infarction, an increase in
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myocardium compared to sham hearts. This difference in Ca2+-
sensitivity of force was abolished after incubation of MI and sham
cells with exogenous protein kinase A (PKA), the downstream kinase of
the β-AR [5,8,10]. This indicated that the increased baseline Ca2+-
sensitivity is due to reduced PKA-mediated phosphorylation of
myoﬁlament target proteins.
Until present, myoﬁlament properties in cardiomyocytes from post-
MI remodeled hearts have been studied in cardiac samples, whichwere
obtained under baseline conditions, i.e. after excision of the heart from
the anesthetized animals. In the present study, we assessed dynamic
changes in myoﬁlament function and protein phosphorylation in
response to β-AR stimulation in a large animal model. Speciﬁcally we
tested the hypothesis that the blunted increase in in vivo pump function
with exercise after MI is due to reducedmyoﬁlament responsiveness to
β-AR stimulation. Cardiomyocyte function and phosphorylation levels
of the main PKA target proteins, myosin-binding protein-C (cMyBP-C)
and troponin I (cTnI) [15–17], were analyzed in small needle biopsies
obtained frompigmyocardium before and during dubutamine infusion.
LV biopsies remote from the infarct area were taken 3 weeks after
surgery. Tissue was harvested under well-controlled conditions and in
vivo hemodynamic data were collected at the time of biopsy
procurement.
2. Materials and methods
2.1. Myocardial infarction
Experiments were performed in accordance with the Guide for the
Care and Use of Laboratory Animals (NIH Publication 86-23, revised
1996), andwith approval of the Animal Care Committee of the Erasmus
Medical Center. Twenty-eight 2–3 month old Yorkshire–Landrace pigs
of either sex entered the study. Pigswere sedated (ketamine, 20 mg/kg i.
m., andmidazolam, 0.5 mg/kg i.m.), anesthetized (thiopental, 10 mg/kg
i.v.), intubated and ventilated with O2 and N2O to which 0.1–1% (vol/
vol) isoﬂurane was added [5,18]. Anesthesia was maintained with
midazolam (2 mg/kg i.v.) and fentanyl (10 μg/kg per hour i.v.). Under
sterile conditions, the chest was opened via the fourth left intercostal
space and a 4 cm incision was made in the pericardium at the site of
the origin of the left circumﬂex coronary artery (LCx). Then, the LCx
was dissected out and a suture was placed around it. The LCx was
permanently ligated to produce a myocardial infarction in 15 pigs (MI
group), whereas in the 13 remaining animals the suture was removed
(sham group). The chest was closed and the animals were allowed to
recover, receiving analgesia (0.3 mg buprenorphine i.m.) for 2 days
and antibiotic prophylaxis (25 mg/kg amoxicillin and 5 mg/kg genta-
mycin i.v.) for 5 days [5,18]. Two animals (one sham and one MI) died
during the surgical procedures and three MI animals died during the
3-week follow-up period.
2.2. In vivo measurements and storage of cardiac tissue samples
Three weeks after surgery, pigs were sedated (ketamine, 20 mg/kg
i.m. andmidazolam, 0.5 mg/kg i.m.). 2D echocardiographic recordings
of the left ventricular (LV) short axis at midpapillary level were
obtained (ALOKA ProSound SSD-4000; Japan) and stored for off-line
analysis [5,18]. LV end-diastolic cross-sectional area (EDA) and end-
systolic cross-sectional area (ESA) were determined, and ejection
fraction (EF) was calculated as (EDA−ESA)/EDA×100%.
Subsequently, pigs were anesthetized (pentobarbital, 20 mg/kg i.v.),
intubated and ventilated with O2 and N2 [5,18]. Anesthesia was
maintained with pentobarbital (10–15 mg/kg/h i.v.). Animals were
instrumented to allow closed-chest monitoring of heart rate, cardiac
output, mean aortic and pulmonary artery blood pressures, LV pressure
and its ﬁrst derivative dP/dt at LV pressure of 40 mmHg (LVdP/dtP40)
and indices of diastolic function, including LVdP/dtmin, the time constantof exponential LV pressure decay (tau) and LV end-diastolic pressure
(LVEDP) [5,18]. Subsequently, amidline sternotomywasperformed and
theheartwas suspended inapericardial cradle. Todeterminechanges in
myoﬁlament function and protein phosphorylation upon adrenergic
stimulation, 2–3 transmural needle (thru-cut) biopsies were taken in 7
shamand 6MI animals before (basal) and at the end of two consecutive
10 min i.v. infusions of dobutamine (2 and 10 μg/kg per min: Dob2 and
Dob10; 10 min each) from the LV anterior free wall myocardium and
immediately frozen and stored in liquid nitrogen. In MI pigs biopsies
were taken randomly fromanywhere in the remodeled anterior LVwall,
covering as much as 30% of the non-infarcted left ventricle.
2.3. Cardiomyocyte measurements
Single cardiomyocytes were obtained via mechanical isolation
[19,20]. Before mechanical isolation, tissue was defrosted in relaxing
solution (pH 7.0; in mmol/L: free Mg2+ 1, KCl 145, EGTA 2, ATP 4,
imidazole 10). During the isolation the tissue was kept on ice. Isolated
myocytes were immersed for 5 min in relaxing solution containing 1%
Triton X-100. Triton removes soluble andmembrane-bound kinases and
phosphatases and thereby arrests the phosphorylation status of
myoﬁbrillar proteins. In a previous study protein analysis did not reveal
differences in thephosphorylation status of contractile proteins between
samples taken before and aftermyocyte isolation [20]. To remove Triton,
cellswerewashed twice in relaxingsolution. Thereafter, a singlemyocyte
was attached between a force transducer and a piezoelectric motor.
Isometric forcemeasurementswere performed at 15 °C and a sarcomere
length, measured in relaxing solution, of 2.2 μm. The calcium concentra-
tions of the relaxing and activating solution (pH 7.1) were, respectively,
10−3 and 30 μmol/L. Solutions with intermediate free [Ca2+] were
obtained bymixing of the activating and relaxing solutions. After theﬁrst
control activation at saturating (maximal) [Ca2+], resting sarcomere
length was readjusted to 2.2 μm, if necessary. The second control
measurementwas used to calculatemaximal isometric tension (i.e. force
divided by cross-sectional area). The next 4 to 5 measurements were
carried out at submaximal [Ca2+] followed by a control measurement.
Force values obtained in solutions with submaximal [Ca2+] were
normalized to the interpolated control values. In a number of cells
force measurements were repeated after incubation with the catalytic
subunit of protein kinase A (PKA, 40 min; 20 °C; 100 U/mL, Sigma).
2.4. Myoﬁlament phosphoproteome
Biopsies were TCA (tri-chloro acetic acid)-treated, and phosphory-
lation status of myoﬁlament proteins was determined using ProQ
Diamond phosphostaining (Molecular Probes) [21]. Samples were
separated on a gradient gel (Criterion tris–HCl 4–15% gel, BioRad) and
proteinswere stained for 1 hwith ProQDiamond Phosphoprotein Stain.
Fixation, washing and de-staining were performed according to the
manufacturers guidelines. Staining was visualized using the LAS-3000
Image Reader (FUJI; 460 nm/605 nm Ex/Em; 2 min illumination) and
AIDA software (Raytest) was used for densitometric analysis of all
signals. All protein signals were within the linear range. Subsequently
gels were stained overnight with SYPRO Ruby stain (Molecular Probes)
and visualized with the LAS-3000 (460 nm/605 nm Ex/Em; 2 s
illumination). Since illumination of ProQ Diamond-stained gels for 2 s
did not reveal any signal, the signals obtained after a 2 s illumination
period upon SYPRO Ruby staining are not tainted by ProQ signals.
Moreover, direct SYPRO staining of proteins yielded similar protein
signals as SYPRO staining following ProQ Diamond stain, evident from
the similar cMyBP-C over α-actinin ratio in directly SYPRO-stained
samples (n=6; 0.64±0.02) and samples which were stained with
SYPRO following ProQ Diamond (n=7; 0.65±0.03). This indicates that
the ProQDiamond stain does not inﬂuence binding of SYPRO Ruby stain
to the proteins. All protein signals were visualized using the LAS-3000
Image Reader (FUJI) and signals were analyzed with AIDA software.
Table 1
Anatomical and hemodynamical data measured with closed-chest.
Sham MI
(n=12) (n=11)
Anatomical data
BW (kg) 30±1 31±1
LV weight (g) 88±4 104±4⁎
RV weight (g) 31±3 43±4⁎
LV weight/BW (g/kg) 2.9±0.1 3.4±0.1⁎
LV end-diastolic area (mm2) 937±50 1486±176⁎
LV end-systolic area (mm2) 326±37 974±150⁎
Ejection fraction (%) 65±3 35±3⁎
Hemodynamic data
Cardiac output (L/min) 3.7±0.4 3.0±0.1†
Heart rate (HR, bpm) 115±4 125±15
Stroke volume (mL) 33±3 27±3†
Mean aortic pressure (mmHg) 87±7 92±6
Mean pulmonary artery pressure (mmHg) 16±1 26±3⁎
LVdP/dtP40 (mmHg/s) 1622±137 1314±78⁎
LVdP/dtmin (mmHg/s) −1907±225 −1935±113
Tau (ms) 38±3 45±4†
LV end-diastolic pressure (mmHg) 7±2 13±3⁎
n, number of animals; BW, body weight; LV, left ventricle; RV, right ventricle. ⁎Pb0.05;
†Pb0.10, MI vs. sham in 1-tailed Student's t-test.
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Ruby-stained cMyBP-C (which expression did not differ between
sham and MI [10]) to correct for differences in sample loading. In
addition, protein phosphorylation signals between different gels were
normalized using the PeppermintStick Phosphoprotein marker (Mo-
lecular Probes). This marker contains two phosphorylated proteins
(ovalbumin and β-casein). The ProQDiamond signal for ovalbuminwas
divided by the SYPRO-stained ovalbumin band, which was used as
correction factor for inter-gel differences (amore extensive explanation
of this analysis is given in reference 21).
2.5. Differential myosin binding protein C phosphorylation
CardiacMyBP-C hasmultiple phosphorylation sites [22–24], which
can be phosphorylated by PKA and/or Ca2+-calmodulin protein
kinase-II (CaMKII) giving rise to a complex pattern of cMyBP-C
species. Multiple phosphorylated and unphosphorylated species of
cMyBP-C were analyzed by 2D-gel electrophoresis as described
recently by Yuan et al. [24]. Approximately 75 μg of biopsy tissue
was loaded and proteins were stained with SYPRO Ruby. Proteins
were separated in the ﬁrst dimension based on their pI using
immobiline strips with a pH gradient of 3 to 11 (i.e. isoelectric
focusing step). The well-focused proteins were then separated based
on molecular mass using 12% gels.
2.6. Western blotting
Gel electrophoresis (15% acrylamide gels) and Western blotting
was performed to analyze phosphorylation of cMyBP-C at Ser282
(PSer282 cMyBP-C; dilution 1:1000) [25], bisphosphorylation of
troponin I (cTnI) at Ser23/24 (i.e. PKA sites, dilution 1:500, Cell
signaling), Thr143 phosphorylation on cTnI (dilution 1:500; Abcam),
Thr287-phosphorylated CaMKII (dilution 1:1000; Promega), cytosolic
CaMKII (CaMKII-δC; dilution 1:200; Santa Cruz) and Met281/282-
oxidized CaMKII-δC (dilution 1:200, kind gift from Dr Mark E
Anderson, University of Iowa) [26]. All signals were normalized to
actin, α-actinin or GAPDH (dilution 1:100,000; HyTest) to correct for
differences in protein loading.
2.7. Dihydroethidiumﬂuorescence: detectionof superoxide aniongeneration
Superoxide anion generation in non-infarcted remote myocardi-
um was determined by using dihydroethidium (DHE) ﬂuorescence
[27]. DHE reacts with superoxide anions to form ethidium bromide,
which, in turn, intercalates with DNA to provide nuclear ﬂuorescence
as a marker for superoxide anion generation. LV tissue from 5 sham
and 5 MI hearts was excised and tissue samples were washed in ice-
cold saline, embedded in Tissue-Tek, frozen in liquid nitrogen cooled
isopentane, and stored at−80 °C. Tissue sections of 5 μmwere cut by
using a cryostat, thawmounted on Fisher-Plus slides, and stainedwith
10 μM DHE at 37 °C for 30 min. Fluorescent images were obtained
with a 585-nm long-pass ﬁlter. Generation of superoxide by tissue
was demonstrated by red ﬂuorescent labeling. Images were analyzed
on a microscopy image analysis system (Impak C, Clemex vision
image analysis system, Clemex Technologies, Longueuil, QC, Canada)
to quantify the amount of ﬂuorescence.
2.8. Data analysis
Data are given as means±SEM. Baseline data in the 2 groups were
compared using unpaired Student's t-test. Dobutamine effects were
tested using 2-way (intergroup) and 1-way (intragroup) repeated
measures ANOVA followed by post-hoc paired or unpaired t-tests
with Bonferroni correction, as appropriate. Effects of PKA were tested
by paired Student's t-tests. Signiﬁcance was accepted when Pb0.05.3. Results
3.1. Blunted in vivo cardiac responsiveness to β-adrenergic receptor
stimulation
Threeweeksafter infarction, signiﬁcant LV remodelinghadoccurred,
as reﬂected in signiﬁcant dilation and hypertrophy of the surviving LV
myocardium (Table 1). LV systolic dysfunction was evidenced by
reduced ejection fraction, stroke volume and LVdP/dtp40. Impaired
diastolic function was evident from the slowed LV pressure decay (tau)
and increased LVEDP in MI compared to sham animals. Pulmonary
artery pressure and right ventricular weight were signiﬁcantly
increased in the MI group, reﬂecting pulmonary congestion.
Dobutamine infusion (sham n=7; MI n=6) produced signiﬁcant
dose-dependent increases in heart rate and in LVdP/dtP40, an acceler-
ation of the LV pressure decay and a decrease in LVEDP (Pb0.05 in
2-way repeated measures ANOVA; Fig. 1). In MI pigs, the relation
between heart rate and LVdP/dtp40 (Fig. 1A) was shifted downward
reﬂecting global LV systolic dysfunction, while the relations between
heart rate and LV pressure decay (tau, Fig. 1B) and LVEDP (Fig. 1C),
respectively, were shifted upward reﬂecting diastolic dysfunction.
Noteworthy, the dobutamine-induced reduction in LVEDP was larger
and signiﬁcant in MI only (Pb0.05 in 1-way ANOVA).
3.2. Enhanced myoﬁlament responsiveness to dobutamine in remodeled
myocardium
At baseline maximal force development (Fmax) of cardiomyocytes
isolated from remodeled post-MI hearts was signiﬁcantly decreased
compared to cells from sham myocardium (Fig. 2A), while myoﬁla-
ment sensitivity to Ca2+ was signiﬁcantly increased in MI compared
to sham, as illustrated by the leftward shift of the force–Ca2+ relation
(Fig. 2B) and the lower EC50 in MI compared to sham (Fig. 2C). Passive
force (Fpas) and steepness of the force–Ca2+ relation (nH) did not
differ signiﬁcantly between sham and MI (Table 2).
Dobutamine did not signiﬁcantly alter Fmax in sham, while low-
dose dobutamine (Dob2) markedly increased Fmax in MI (Fig. 2A), and
thereby corrected the difference in basal Fmax between sham and MI.
Also at maximal dobutamine stimulation Fmax did not differ between
sham and MI. Dobutamine stimulation decreased Ca2+-sensitivity in
both groups and abolished the difference in EC50 between sham and
MI (Fig. 2C). Of note, the dobutamine-induced shift in EC50 (basal vs.
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Fig. 1. Effect of dobutamine on indices of global systolic and diastolic LV function.
Shown are open-chest measurements of the ﬁrst derivative of LV pressure at a pressure
of 40 mmHg (LVdP/dtP40) (A), LV pressure decay (B, tau) and LV end-diastolic pressure
(C, LVEDP) plotted as a function of heart rate, at baseline and during two consecutive
10 min i.v. infusions of dobutamine (2 and 10 μg/kg per min: Dob2 and Dob10).
#Pb0.05, Dob-effect tested in 1-way ANOVA. Post-hoc Bonferroni analysis: ⁎Pb0.05,
MI (n=6) vs. sham (n=7).
490 N.M. Boontje et al. / Journal of Molecular and Cellular Cardiology 50 (2011) 487–499Dob10) was signiﬁcantly larger in MI (1.11±0.12 μmol/L) compared
to sham (0.53±0.20 μmol/L) (Figs. 2C and D). No signiﬁcant effects
were observed on Fpas and nH (Table 2).
3.3. Enhanced myoﬁlament responsiveness to exogenous protein kinase
A in remodeled myocardium
To assess the contribution of PKA to the dobutamine-induced
effects on myoﬁlament function, force measurements were repeated
in a number of cardiomyocytes after incubation with exogenous PKA
(Table 2). PKA signiﬁcantly reduced Ca2+-sensitivity of the myoﬁla-
ments in sham and MI samples (Fig. 3). The PKA-induced increase inEC50 (indicated in μmol/L) was signiﬁcantly larger in MI than in sham
cells isolated from baseline biopsies (Fig. 3A). Dobutamine diminished
the effect of exogenous PKA on Ca2+-sensitivity (Figs. 3B and C), to a
similar extent in sham and MI pigs, so that at Dob10, PKA no longer
increased EC50 in sham, while a small but signiﬁcant shift was still
present in the MI group (Fig. 3C).
PKA produced a 10% increase in baseline Fmax in sham cells, but
had negligible effects on Fmax during dobutamine in either sham orMI.
In addition, PKA tended to decrease Fpas and increase nH in both sham
andMI at baseline and/or dobutamine, but this was not a (statistically
signiﬁcant) consistent observation.3.4. Diverse phosphorylation pattern of PKA target proteins in response
to dobutamine
At baseline no signiﬁcant differences were observed in ProQ
Diamond stained phosphorylation of the β-AR target proteins, cMyBP-
C and cTnI, while myosin light chain 2 (MLC-2) phosphorylation was
signiﬁcantly lower in MI compared to sham (Fig. 4A). Lower MLC-2
phosphorylation in MI compared to sham was conﬁrmed by two-
dimensional gel electrophoresis (Fig. 1 of online Data Supplement),
which separates the two phosphorylated isoforms of MLC-2 (MLC-2
and MLC-2⁎) [21]. Phosphorylation of the MLC-2 isoform was
signiﬁcantly lower in MI compared to sham (P≤0.05), while
phosphorylation of the MLC-2⁎ isoform was low in sham and below
detection level in MI samples. The absence of a difference in baseline
phosphorylation of the β-AR target proteins was conﬁrmed by
phospho-speciﬁc antibodies directed against Ser282 on cMyBP-C
and the PKA sites Ser23/24 and PKC-site Thr143 on cTnI (Fig. 4B).
Dobutamine increased phosphorylation of the PKA target proteins
cMyBP-C and cTnI. The enhanced phosphorylation of cMyBP-C and
cTnI is illustrated in Fig. 5A, which shows a ProQ Diamond stained gel
of a sham and an MI heart at baseline and after dobutamine
stimulation. MLC-2 phosphorylation tended to increase in sham at
Dob10 (Fig. 5B), while cMyBP-C phosphorylation showed increases
that were similar in both groups (Fig. 5C). In contrast, the marked
increase in phosphorylation of cTnI was less in MI compared to sham,
so that at Dob10, absolute cTnI phosphorylation was signiﬁcantly
lower in MI compared to sham (Fig. 5D). Western blot analysis also
showed a diverse phosphorylation pattern of the PKA target proteins
upon dobutamine stimulation in the MI group (Figs. 6A and B).
Dobutamine increased phosphorylation at Ser282 on cMyBP-C
(Fig. 6A) in sham and MI (Pb0.05 in 2-way ANOVA for effect of
dobutamine; interaction P=0.93). Post-hoc test analysis showed that
the effect of dobutamine was signiﬁcant in the MI group (Pb0.05; and
P=0.14 for sham). In accordance with the ProQ Diamond stain
analysis of overall cTnI phosphorylation, the increase in cTnI
phosphorylation at PKA-sites upon dobutamine was attenuated in
MI compared to sham myocardium (Fig. 6B). Phosphorylation of
desmin and cardiac troponin T (cTnT) determined on ProQ-Diamond
stained gels did not differ between groups, both at baseline and upon
dobutamine (not shown).
Two-dimensional gel electrophoresis was performed to study
phosphorylation of cMyBP-C in more detail. Fig. 7 shows 2D gels from
sham biopsies taken at baseline (panel A) and after maximal
dobutamine stimulation (Dob10; panel B). Multiple spots (numbered
1 to 10) were found at the level of cMyBP-C, which represent different
cMyBP-C species [24]. At baseline, no signiﬁcant difference was found
in the pattern of cMyBP-C species between the sham (n=5) and MI
(n=5) groups (Fig. 7A). Dobutamine induced a shift of the protein
spots to the acidic site compared to baseline indicative for
phosphorylation of cMyBP-C (Fig. 7B) [24]. A similar leftward shift
was observed in all sham andMI samples and no signiﬁcant difference
was observed in the distribution of cMyBP-C species after maximal
dobutamine stimulation between sham and MI pigs.
Fig. 2. Effect of dobutamine on myoﬁlament function. Force measurements were performed in cells isolated from biopsies taken during dobutamine (Dob) infusion (2 and 10 μg/kg
per minute; Dob2 and Dob10) and compared to baseline myoﬁlament force (BL). (A) At baseline, maximal force (Fmax) was signiﬁcantly lower in MI compared to sham, while Ca2+-
sensitivity of force was signiﬁcantly higher evident from the leftward shift of the force–calcium relation in MI compared to sham (B). Fmax increased upon dobutamine infusion only
in MI (A), while EC50 increased in all groups (C). Force–calcium relations at baseline and after maximal dobutamine stimulation are shown in panel D and illustrate that the
dobutamine-induced reduction in Ca2+-sensitivity of force was signiﬁcantly larger in MI compared to sham. The number of cells isolated from the biopsies from both groups is given
in the bars of panel A. #Pb0.05, Dob-effect tested in 1-way ANOVA. Post-hoc Bonferroni analysis: ⁎Pb0.05, MI vs. sham; ‡Pb0.05, Dob vs. BL.
Table 2
Force characteristics in single cardiomyocytes before and after protein kinase A.
Sample Before PKA After PKA Effect PKA
Fmax Fpas EC50 nH Fmax Fpas EC50 nH Change in EC50
Baseline
Sham (n=5) 39.6±6.5 6.8±1.1 2.96±0.19 3.36±0.17 44.0±6.8‡ 6.0±0.8 3.79±0.18‡ 3.55±0.28 0.82±0.15
MI (n=5) 21.6±2.6⁎ 8.0±0.9 2.18±0.08⁎ 2.89±0.15 22.1±2.6⁎ 6.4±0.8 3.34±0.13⁎‡ 3.10±0.12 1.15±0.09⁎
Dob2
Sham (n=7) 27.3±2.6 4.1±0.4 3.26±0.18 3.47±0.17 27.3±2.5 3.1±0.5‡ 3.87±0.13‡ 3.84±0.21‡ 0.60±0.09
MI (n=6) 38.4±2.3 7.5±2.2 2.64±0.17 3.36±0.16 36.6±1.5 6.3±1.9‡ 3.25±0.21⁎‡ 3.77±0.19‡ 0.61±0.09
Dob10
Sham (n=5) 28.2±2.5 4.5±0.5 3.48±0.23 3.50±0.31 29.8±2.6 4.2±0.8 3.53±0.23 3.74±0.34 0.05±0.05
MI (n=8) 27.3±2.9 4.9±0.8 3.33±0.10 3.78±0.18 28.5±2.8‡ 4.1±0.7‡ 3.74±0.10‡ 3.55±0.17 0.41±0.16⁎
Fmax and Fpas are expressed in kN/m2; EC50 is expressed in μmol/L. nH, steepness of force–calcium relation. Abbreviations: PKA, protein kinase A; n, number of cells. Dob2 and Dob10,
dobutamine 2 and 10 μg/kg per min. ⁎Pb0.05, MI vs. sham in unpaired t-test. ‡Pb0.05, before vs. after PKA in paired Student's t-test.
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Fig. 3. Effect of exogenous protein kinase A on myoﬁlament function. Force–calcium relations in sham and MI cells isolated from biopsies which were taken at baseline and during
dobutamine (Dob2 and Dob10) stimulation. Force was measured at different calcium concentrations before and after PKA treatment. Incubation of cells with exogenous PKA
decreased Ca2+-sensitivity in all samples. The PKA-induced shift in EC50 (in μmol/L) in baseline samples (BL)was larger inMI than in sham (A) andwas reduced by dobutamine (Dob)
stimulation (B and C). (C) In Dob10 samples, exogenous PKA signiﬁcantly reduced Ca2+-sensitivity in MI, while no signiﬁcant effect was observed in sham. ⁎Pb0.05, MI vs. sham.
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post-infarct myocardium
The blunted increase in cTnI phosphorylation upon β-AR stimu-
lation in MI compared to sham with preserved phosphorylation of
cMyBP-C may be explained by activation of kinases other than PKA,
such as Ca2+-dependent calmodulin kinase II (CAMKII-δ) [22].
Increased expression and activity of CaMKII have been observed in
failing myocardium [28,29]. Moreover, CaMKII is activated by
enhanced intracellular calcium upon β1-AR stimulation (autopho-
sphorylation at Thr287) and by oxidation (at Met281/282) [26,30,31].
In the present study, increased DHE ﬂuorescence was found in MI
compared to sham myocardium, indicative for enhanced superoxide
anion generation in remote remodeled myocardium (Fig. 2 of online
Data Supplement).Western blot analyses were performed to investigate if CaMKII-δ is
up-regulated in post-infarct remodeled myocardium and activated
during dobutamine stimulation. Two bands were observed at the level
of CaMKII (Fig. 8A), of which the upper band is the nuclear and the
lower band is the cytosolic (CAMKII-δC) isoform. The analysis
revealed increased expression of the CAMKII-δC (normalized to
GAPDH) in MI compared to sham (Fig. 8B). At baseline, the total
level of oxidized CaMKII-δC (Met281/282) normalized to GAPDH was
higher in MI than in sham (Fig. 8C), while autophosphorylation of
CAMKII-δC at Thr287 normalized to GAPDH did not differ between
sham and MI (Fig. 8D). However, as CAMKII-δC expression was
increased in MI, no difference was observed in Met281/282 oxidized
CaMKII-δC when normalized to total CaMKII-δC (Fig. 8E). Further-
more, the ratio of Thr287 autophosphorylated CAMKII-δC to total
CaMKII-δC expression was lower in MI than in sham (Fig. 8F). Beta-
Fig. 4. Baseline myoﬁlament protein phosphorylation. (A) ProQ Diamond staining of samples taken at baseline showed no differences in phosphorylation of the PKA target proteins,
myosin binding protein C (cMyBP-C) and troponin I (cTnI), while a signiﬁcantly lower myosin light chain 2 (MLC-2) phosphorylation was found in MI compared to sham. MI values
were normalized to the sham values, which were set to 1. (B) In line with the ProQ Diamond analysis of protein phosphorylation, Western blot analysis did not reveal a difference in
baseline cMyBP-C phosphorylated on Ser282 and cTnI phosphorylated at Ser23/24 and Thr143 between groups. MI values were normalized to the sham values on the same blot,
which was set to 1. The number of analyzed samples is given in the bars. ⁎Pb0.05 MI vs. sham in unpaired t-test.
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sion or oxidation (Met281/282; Fig. 8G) of CAMKII-δC in either sham
or MI, but signiﬁcantly increased the ratio of Thr287 autophosphor-
ylated CaMKII-δC to total CaMKII-δC in MI (Fig. 8H).
4. Discussion
The present study investigated dynamic changes in myoﬁlament
function and in protein phosphorylation in response to β-AR
stimulation in post-infarct remodeled myocardium. Dobutamine
increased the maximal force generating capacity of cardiomyocytes
only in MI and reduced myoﬁlament Ca2+-sensitivity to a greater
extent in MI compared to sham. Unexpectedly, we observed
maintained baseline phosphorylation levels of the PKA target
proteins, cMyBP-C and cTnI, in remodeled post-MI myocardium incomparison to sham hearts. However, dobutamine-induced PKA-
mediated phosphorylation of cTnI was signiﬁcantly attenuated in
post-MI remodeled hearts. Taken together, our data do not support
the hypothesis that myoﬁlament responsiveness to β-adrenergic
stimulation is blunted in post-infarct remodeled myocardium.
4.1. Correction of maximal myoﬁlament force
In accordance with previous studies [5–10] our data indicate that
the baseline maximal myoﬁlament force generating capacity of non-
infarcted cardiomyocytes from remodeled post-MI hearts is reduced
compared to sham cells. As the difference in Fmax was abolished upon
a low dose of dobutamine infusion, it is unlikely that reduced
myoﬁbrillar density, protein degradation or increased oxidative stress
are causal for the reduction in baseline Fmax. Analysis of myoﬁbrillar
Fig. 5. Effect of dobutamine of protein phosphorylation. (A) ProQ Diamond stained gel of samples from a sham and an MI heart taken at baseline (BL) and upon dobutamine (Dob, 2
and 10 μg/kg/min) illustrates increased phosphorylation of the PKA target proteins, myosin binding protein C (cMyBP-C) and troponin I (cTnI) upon dobutamine. (B) A slight, though
not signiﬁcant, increase in myosin light chain 2 (MLC-2) phosphorylation was observed in sham myocardium upon dobutamine. (C) Dobutamine increased phosphorylation of
cMyBP-C to a similar extent in sham and MI myocardium. (D) The dobutamine-induced increase in cTnI phosphorylation was larger in sham compared to MI myocardium. At
maximal dobutamine (Dob10) cTnI phosphorylation was signiﬁcantly lower inMI compared to sham. Protein phosphorylation in samples taken after dobutamine was normalized to
baseline phosphorylation, which was set to 1. Protein analysis was performed in samples taken at baseline and after dobutamine (Dob2 and Dob10) from 7 sham hearts and 6 MI
hearts. #Pb0.05, effect of dobutamine in 1-way ANOVA; ⁎Pb0.05 MI vs. sham in unpaired t-test.
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sham and MI samples (Fig. 3 of online Data Supplement).
In a recent study we observed enhanced protein phosphatase 1
(PP1) expression in MI myocardium [10], which may account for the
reductions in baseline MLC-2 phosphorylation and in Fmax. The role of
cardiac MLC-2 phosphorylation in cardiac performance has been
studied by Scruggs and colleagues [32] in a transgenic mouse model
expressing cardiac-speciﬁc non-phosphorylatable MLC-2. Maximal
force of skinned trabeculae from the transgenic mice with non-
phosphorylatable MLC-2 was signiﬁcantly lower compared to non-
transgenic mice. Thus, the signiﬁcantly lower MLC-2 phosphorylation
observed in MI pigs compared to shammyocardiummay underlie the
signiﬁcantly lower force generating capacity in MI cells at baseline.
However, in our previous study [10] we investigated the effect of PP1-
mediated MLC-2 dephosphorylation on myoﬁlament function and didnot observe a signiﬁcant change in maximal force, both in sham and
MI cells, despite a signiﬁcant reduction in MLC-2 phosphorylation
[10]. Moreover, in the present study Fmax increased in MI myocardium
upon dobutamine without a concomitant increase in MLC-2 phos-
phorylation, suggesting that the reduced baseline Fmax in post-infarct
remodeled myocardium cannot be explained by an increased PP1-
mediated reduction in MLC-2 phosphorylation.
Previous studies suggest that CaMKII-mediated phosphorylation of
cMyBP-C is involved in increasing the force generating capacity of
myocardium [33,34]. Tong et al. [34] showed in intact cardiac muscle
that the frequency-dependent increase in maximal active force was
depressed by inhibition of CaMK-II, without a change in calcium
transient. Moreover, in the latter study CaMK-II inhibition reduced
phosphorylation of cMyBP-C. In the present study, dobutamine
increased phosphorylation of CaMKII-δC solely in the MI group
Fig. 6. Effect of dobutamine of protein phosphorylation. (A) Western blot analysis showed similar increases in myosin binding protein C (cMyBP-C) phosphorylation at Ser282 upon
dobutamine in sham and MI. (B) Bisphosphorylation at PKA-sites Ser23/24 on troponin I (cTnI) increased upon dobutamine. The dobutamine-induced phosphorylation at Ser23/24
on cTnI was less in MI compared to sham. Protein phosphorylation signals at Dob2 and Dob10 were normalized to baseline signals (set to 1) of samples run on the same gel. The
number of analyzed samples is given in the bars. #Pb0.05, effect of dobutamine in 1-way ANOVA; ⁎Pb0.05 MI vs. sham in unpaired t-test.
Fig. 7. Differential phosphorylation of cMyBP-C. Two-dimensional gel analysis of sham biopsies taken at baseline (A) and after maximal dobutamine stimulation (Dob10) (B) revealed
multiple spots at the level of cMyBP-C,which represent unphosphorylated andphosphorylated species of cMyBP-C [24]. The intensities of the cMyBP-C species, expressed as percentage of
the total cMyBP-C signal on the 2Dgels, did not differ between shamandMI samples at baseline (A; right graph). (B) Dobutamine shifted the cMyBP-C spots to the left andmore acidic side
of the gels, indicative for increased cMyBP-C phosphorylation. Similar to baseline, the cMyBP-C spot intensities uponmaximal stimulation with dobutamine did not differ between sham
and MI samples (B; right graph).
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Fig. 9. Ca2+-sensitivity of force (EC50) at baseline and after two consecutive
dobutamine infusions (2 and 10 μg/kg per min; Dob2 and Dob10) plotted against
phosphorylation of cMyBP-C (A) and cTnI (B) to illustrate the enhanced change in EC50
upon dobutamine in MI compared to sham and preserved cMyBP-C phosphorylation,
while dubutamine-induced phosphorylation of cTnI is blunted in MI compared to sham.
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dobutamine-induced changes in intracellular calcium could activate
other kinases within the cell, with CaMKII being a major candidate
[30,31]. Thus, the increase in Fmax upon dobutamine in remodeled post-
MImyocardiummay involve increased CaMKII-δC-mediated phosphor-
ylation of cMyBP-C upon β-AR stimulation.
It should be noted that the major signiﬁcant increase in Fmax in MI
myocardium was observed at low dose dobutamine (Dob2; Fig. 2A,
Table 2). Fmax at maximal dobutamine stimulation (Dob10) tended to
be lower in sham and MI compared to the baseline value observed in
sham, though did not differ between sham and MI. On the basis of
these data we conclude that the depressed baseline maximal force in
MI compared to sham is abolished upon β-AR stimulation.
4.2. Enhanced myoﬁlament Ca2+-sensitivity and stronger response to
β-adrenergic receptor stimulation in remodeled myocardium
In healthy myocardium, the reduction in myoﬁlament Ca2+-
sensitivity and enhanced cross-bridge kinetics uponPKA-mediated phos-
phorylation of cTnI and cMyBP-C following activation of β-adrenergic
receptors, are thought to improve myocardial relaxation [35–37]. Failure
to enhance cardiac performance in post-infarct remodeled hearts during
exercise to a similar level as observed in sham [5] and reversal of the
increased myoﬁlament Ca2+-sensitivity with exogenous PKA to values
seen in sham (Table 2) point towards defective β-AR signaling and
reduced PKA-mediated phosphorylation as the potential underlying
mechanism of the increased baseline Ca2+-sensitivity in MI pigs. In
further support for that notion, we found in the present study that the
dobutamine-induced increase in phosphorylation of the β-AR target
protein cTnI was only 48% of the increase in sham hearts. Blunted cTnI
phosphorylation upon dobutamine stimulation was conﬁrmed by
Western blot analysis which showed a reduced β-AR mediated increase
in cTnI phosphorylation at PKA-sites (Ser23/24) in MI compared to
sham. However, despite these observations pointing towards defective
β-AR/PKA signaling, baseline phosphorylation status of the PKA-target
proteins cTnI and cMyBPCwere unchanged inMI compared to sham.On
the basis of our data we propose that enhanced myoﬁlament Ca2+-
sensitivity in post-MI remodeled myocardium at baseline is not caused
by hypophosphorylation of PKA sites in cMyBP-C (Ser282) and cTnI
(Ser23/24), butmay involve reducedprotein phosphorylation causedby
increased activity of PP1 [10]. In samples which were taken before
dobutamine infusion we found a reduced phosphorylation of MLC-2 in
MI compared to sham. Sweeney and Stull [38] have shown that MLC-2
phosphorylationbymyosin light chain kinase increases Ca2+-sensitivity
of force. Accordingly, PP-1 treatment of human cardiomyocytes
decreased MLC-2 phosphorylation with a concomitant reduction in
myoﬁlament Ca2+-sensitivity [20]. Based on these previous studies it is
unlikely that reducedMLC-2 phosphorylation is causal for the enhanced
baseline myoﬁlament Ca2+-sensitivity observed in MI myocardium.
Opposite to our expectations, myoﬁlament responsiveness to β-AR
stimulationwasenhanced inMI compared to shampigs illustratedbyan
augmented shift in EC50, suggesting unperturbed myoﬁlament respon-
siveness to β-AR signaling. Although, dobutamine-induced cTnI
phosphorylationwasblunted inMI compared to sham, phosphorylation
of cMyBP-C was preserved. As illustrated in Fig. 9, the dobutamine-
induced changes in myoﬁlament Ca2+-sensitivity coincide with similar
increases in cMyBP-C phosphorylation in MI and sham hearts (Fig. 9A),
while the relation between EC50 and cTnI phosphorylation is strikinglyFig. 8. Ca2+-dependent calmodulin kinase II. Western blot analysis of CAMKII-δ in sham a
showed two CAMKII-δ bands: the upper band is the nuclear form, while the lower band is th
to GAPDH was signiﬁcantly higher in MI compared to sham samples. (C) In addition, incre
compared to sham, while the phosphorylated CAMKII-δC (at Thr 287) did not differ between
signiﬁcantly higher in MI compared to sham, no signiﬁcant differences were observed betwe
287, F) upon normalization to total CAMKII-δC. Bar graphs in panel B-F: data in MI were norm
oxidation of CAMKII-δC (G), while it signiﬁcantly increased phosphorylation of CAMKII-δC a
after dobutamine were normalized to baseline values, which were set to 1. †Pb0.10, MI vs.different between MI and sham (Fig. 9B). Cazorla et al. [37] observed
that the PKA-mediated myoﬁlament Ca2+-desensitization was lost in
transgenic mice lacking cMyBP-C, illustrating that cMyBP-C phosphor-
ylation is required for the reduction in Ca2+-sensitivity upon β-AR
stimulation. In a recent study, we have shown that cMyBP-C and/or titin
play an important role in modulating the effect of PKA-mediated cTnI
phosphorylation on Ca2+-sensitivity in human myocardium [39].
Hence, the enhanced myoﬁlament responsiveness to dobutamine may
be a consequence of the preserved phosphorylation of cMyBP-C which,
in view of the blunted phosphorylation of cTnI, possibly involves
enhanced autophosphorylation (activation) of CaMKII-δC. Further
studies are needed to deﬁne the speciﬁc role of CaMKII and protein
phosphatases in the myoﬁlament dysfunction of post-MI remodeled
myocardium.
4.3. Study limitations
The absence of a difference in baseline phosphorylation of the PKA
target proteins between MI and sham hearts may be related to a
difference in catecholamine levels. However, in a previous study [18]
we have measured norepinephrine and epinephrine in arterial blood
samples which were collected in the morning from awake animals
and found no difference between MI and sham pigs up to 6 weeks
after surgery. Accordingly, in the present study we did not observe and MI samples taken at baseline and after dobutamine stimulation. (A) Western blots
e cytosolic form of CAMKII-δ (CAMKII-δC). (B) The expression of CAMKII-δC normalized
ased oxidation (Met 281/282) of CAMKII-δC (normalized to GAPDH) was found in MI
sham and MI when corrected for GAPDH (D). However, as CAMKII-δC expression was
en sham and MI in the oxidized form (Met 281/282, E) or the phosphorylated form (Thr
alized to the value observed in sham, which was set to 1. Dobutamine did not alter the
t Thr287 in MI, but not in sham (H). Bar graphs in G-H: Protein values in samples taken
sham in unpaired t-test. ‡Pb0.05, Dob vs. BL.
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closed (Table 1) and open (Fig. 1) chest). We are therefore conﬁdent
that there are no signiﬁcant differences in catecholamine levels at
baseline. An alternative explanation for the absence of a difference in
PKA-mediated protein phosphorylation may involve a stress response
induced during procurement of transmural biopsies. We believe a
stress response is unlikely to play a role, as this would increase
phosphorylation levels in biopsies which were retrieved at baseline.
In a recent study [40] we have analyzed protein phosphorylation in
small biopsies and larger LV tissue samples from patients with
hypertrophic cardiomyopathy and found no indications for a stress
response during biopsy procurement, as phosphorylation levels in the
small biopsies were similar to values observed in tissue from larger
samples, in which a stress response is less likely to occur. Moreover,
the biopsies taken before dobutamine in the present study have
protein phosphorylation levels similar to values observed in larger
tissue samples from pig hearts [41].
5. Conclusions
On the basis of our previous studies [5,10] we hypothesized that
reduced myoﬁlament responsiveness would contribute to the blunted
increase in pump function with exercise in MI animals. Although
baseline Fmax and EC50 were reduced our data demonstrate that
myoﬁlament responsiveness to acuteβ-adrenergic receptor stimulation
is, unexpectedly, enhanced in post-infarct remodeled myocardium, as
illustrated by the increase in Fmax and large shift in EC50. The enhanced
dobutamine-induced myoﬁlament responsiveness in post-MI remo-
deled myocardium may be the consequence of the increased baseline
Ca2+-sensitivity,whichmaybroaden thedynamic rangeofmyoﬁlament
responsiveness to β-AR stimulation, aswell as the preserved phosphor-
ylation of cMyBP-C. The enhanced myoﬁlament responsiveness to
dobutamine may oppose the effects of ﬁbrosis and impaired Ca2+-
handling, which limit relaxation of the diseased heart, to minimize
diastolic and thereby systolic cardiac dysfunction during exercise.
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